LivingGLP1
Study S001114

Effects of the GLP-1 Exenatide on Intrinsic Brain Activity in Lean and Obese Women

Registration

Registration
NCT01501084
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
TRIPLE
Status
COMPLETED
Enrollment
34
Start
2011-12
Primary completion
2012-12
Lead sponsor
University of California, Los Angeles
Conditions
Obesity
Interventions
DRUG:Exenatide; DRUG:Normal saline .2cc subcutaneous injection
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Resting State networks in the brain [one year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.